These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 36622795)
21. TLR9 expression in uterine cervical lesions of Uyghur women correlate with cervical cancer progression and selective silencing of human papillomavirus 16 E6 and E7 oncoproteins in vitro. Hao Y; Yuan JL; Abudula A; Hasimu A; Kadeer N; Guo X Asian Pac J Cancer Prev; 2014; 15(14):5867-72. PubMed ID: 25081715 [TBL] [Abstract][Full Text] [Related]
22. Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells. Ding W; Hu Z; Zhu D; Jiang X; Yu L; Wang X; Zhang C; Wang L; Ji T; Li K; He D; Xia X; Liu D; Zhou J; Ma D; Wang H Clin Cancer Res; 2014 Dec; 20(24):6495-503. PubMed ID: 25336692 [TBL] [Abstract][Full Text] [Related]
23. Evidence that the viral oncoproteins E6 and E7 of HPV induce the expression of a functional IL-2R on cervical cancer cells. Trujillo-Cirilo L; Torres-Corioriles EI; Rangel-Corona R; Corona-Ortega MT; Weiss-Steider B Cytokine; 2021 Dec; 148():155592. PubMed ID: 34099345 [TBL] [Abstract][Full Text] [Related]
24. CREB1 activation promotes human papillomavirus oncogene expression and cervical cancer cell transformation. Li Y; Patterson MR; Morgan EL; Wasson CW; Ryder EL; Barba-Moreno D; Scarth JA; Wang M; Macdonald A J Med Virol; 2023 Aug; 95(8):e29025. PubMed ID: 37565725 [TBL] [Abstract][Full Text] [Related]
25. miR-135a leads to cervical cancer cell transformation through regulation of β-catenin via a SIAH1-dependent ubiquitin proteosomal pathway. Leung CO; Deng W; Ye TM; Ngan HY; Tsao SW; Cheung AN; Pang RT; Yeung WS Carcinogenesis; 2014 Sep; 35(9):1931-40. PubMed ID: 24503442 [TBL] [Abstract][Full Text] [Related]
26. Systemic delivery of siRNA by actively targeted polyion complex micelles for silencing the E6 and E7 human papillomavirus oncogenes. Nishida H; Matsumoto Y; Kawana K; Christie RJ; Naito M; Kim BS; Toh K; Min HS; Yi Y; Matsumoto Y; Kim HJ; Miyata K; Taguchi A; Tomio K; Yamashita A; Inoue T; Nakamura H; Fujimoto A; Sato M; Yoshida M; Adachi K; Arimoto T; Wada-Hiraike O; Oda K; Nagamatsu T; Nishiyama N; Kataoka K; Osuga Y; Fujii T J Control Release; 2016 Jun; 231():29-37. PubMed ID: 26979870 [TBL] [Abstract][Full Text] [Related]
27. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line. Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640 [TBL] [Abstract][Full Text] [Related]
28. HPV E6/E7: insights into their regulatory role and mechanism in signaling pathways in HPV-associated tumor. Peng Q; Wang L; Zuo L; Gao S; Jiang X; Han Y; Lin J; Peng M; Wu N; Tang Y; Tian H; Zhou Y; Liao Q Cancer Gene Ther; 2024 Jan; 31(1):9-17. PubMed ID: 38102462 [TBL] [Abstract][Full Text] [Related]
29. Distribution of human papilloma virus type 16 E6/E7 gene mutation in cervical precancer or cancer: A case control study in Guizhou Province, China. Yang Y; Ren J; Zhang Q J Med Virol; 2016 Feb; 88(2):345-50. PubMed ID: 26192265 [TBL] [Abstract][Full Text] [Related]
30. Human telomerase reverse transcriptase regulates vascular endothelial growth factor expression via human papillomavirus oncogene E7 in HPV-18-positive cervical cancer cells. Li F; Cui J Med Oncol; 2015 Jul; 32(7):199. PubMed ID: 26067630 [TBL] [Abstract][Full Text] [Related]
31. E6/E7 oncoproteins of high risk HPV-16 upregulate MT1-MMP, MMP-2 and MMP-9 and promote the migration of cervical cancer cells. Zhu D; Ye M; Zhang W Int J Clin Exp Pathol; 2015; 8(5):4981-9. PubMed ID: 26191191 [TBL] [Abstract][Full Text] [Related]
32. Feasibility study of a human papillomavirus E6 and E7 oncoprotein test for the diagnosis of cervical precancer and cancer. Zhang JJ; Cao XC; Zheng XY; Wang HY; Li YW J Int Med Res; 2018 Mar; 46(3):1033-1042. PubMed ID: 29322839 [TBL] [Abstract][Full Text] [Related]
33. Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells. He H; Liu X; Liu Y; Zhang M; Lai Y; Hao Y; Wang Q; Shi D; Wang N; Luo XG; Ma W; Zhang TC J Virol; 2019 Apr; 93(8):. PubMed ID: 30728257 [TBL] [Abstract][Full Text] [Related]
34. High-risk human papillomavirus E6/E7 mRNA and L1 DNA as markers of residual/recurrent cervical intraepithelial neoplasia. Persson M; Brismar Wendel S; Ljungblad L; Johansson B; Weiderpass E; Andersson S Oncol Rep; 2012 Jul; 28(1):346-52. PubMed ID: 22484610 [TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus E7 binds Oct4 and regulates its activity in HPV-associated cervical cancers. Panayiotou T; Michael S; Zaravinos A; Demirag E; Achilleos C; Strati K PLoS Pathog; 2020 Apr; 16(4):e1008468. PubMed ID: 32298395 [TBL] [Abstract][Full Text] [Related]
36. Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR/Cas RNA-guided endonuclease. Kennedy EM; Kornepati AV; Goldstein M; Bogerd HP; Poling BC; Whisnant AW; Kastan MB; Cullen BR J Virol; 2014 Oct; 88(20):11965-72. PubMed ID: 25100830 [TBL] [Abstract][Full Text] [Related]
37. Piwil2 is reactivated by HPV oncoproteins and initiates cell reprogramming via epigenetic regulation during cervical cancer tumorigenesis. Feng D; Yan K; Zhou Y; Liang H; Liang J; Zhao W; Dong Z; Ling B Oncotarget; 2016 Oct; 7(40):64575-64588. PubMed ID: 27602489 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of cervical cancer cell growth by human papillomavirus virus-like particles packaged with human papillomavirus oncoprotein short hairpin RNAs. Bousarghin L; Touze A; Gaud G; Iochmann S; Alvarez E; Reverdiau P; Gaitan J; Jourdan ML; Sizaret PY; Coursaget PL Mol Cancer Ther; 2009 Feb; 8(2):357-65. PubMed ID: 19174559 [TBL] [Abstract][Full Text] [Related]